Arbitel-MT 50 Tablet ER
Marketer
Micro Labs Ltd
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (50mg)
Overview Arbitel-MT 50 Tablet ER
Extended-release Arbitel-MT 50mg tablets manage hypertension, reducing the risk of stroke and myocardial infarction. Prompt treatment enhances survival rates following a heart attack. Consistent blood levels are achieved by taking the medication with food at the same time daily, as prescribed by your physician. Continue treatment as directed; discontinuation, even feeling well, can worsen hypertension, often asymptomatic. Lifestyle modifications—including regular exercise, weight management, and a healthy diet—complement medication. Adhere strictly to your doctor's instructions. Potential side effects include headache, weakness, lightheadedness, hypotension, hyperkalemia, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, glucose, renal function, urea, and electrolytes may be necessary. Inform your doctor of any kidney or liver issues before commencing treatment. Pregnant or lactating individuals should consult their physician before use. Disclose all medications, particularly those for hypertension or cardiac conditions.
Uses of Arbitel-MT 50 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Arbitel-MT 50 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Arbitel-MT 50 Extended-Release Tablet should be administered with a meal.
Common Side effects of Arbitel-MT 50 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Arbitel-MT 50 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Arbitel-MT 50 Extended-Release Tablet should be administered with a meal.
How Arbitel-MT 50 Tablet ER works:
Arbitel-MT 50 Extended-Release tablets contain a dual-action formulation of telmisartan and metoprolol succinate, both effective in reducing high blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Arbitel-MT 50 Tablet ER is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Arbitel-MT 50 tablets are contraindicated in pregnancy due to established fetal risk. Exceptions may be made in life-threatening circumstances where the potential benefits outweigh the known hazards, at the sole discretion of the prescribing physician. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Arbitel-MT 50 tablets are likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Extended-release Arbitel-MT 50 tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Arbitel-MT 50 tablets are considered safe for patients with kidney impairment. No alteration to the Arbitel-MT 50 Tablet ER dosage is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Arbitel-MT 50 Tablet ER. Dosage modification of Arbitel-MT 50 Tablet ER may be necessary. Physician consultation is recommended.
What if you forget to take Arbitel-MT 50 Tablet ER :
Should you forget to take a scheduled Arbitel-MT 50 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Arbitel-MT 50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |



